Vitebsk State Medical University Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2020
NCT04608760
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Vitebsk State Medical University

Active Ingredients

Drugs in Phase 1 Trials (1)

ethylmethylhydroxypyridine succinate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pancreatitis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1